Dialysis independence following single-agent daratumumab in refractory myeloma with renal failure.

Smyth, Elizabeth; Glavey, Siobhan; Melotti, Dario; Thornton, Patrick; Sargent, Jeremy; Conlon, Peter; Murphy, Philip; Quinn, John

Smyth, Elizabeth; Glavey, Siobhan; Melotti, Dario; Thornton, Patrick; Sargent, Jeremy; Conlon, Peter; Murphy, Philip; Quinn, John.

Afiliação

Smyth E; Department of Haematology, Beaumont Hospital, Dublin 9, Beaumont, Ireland.
Glavey S; Department of Haematology, Beaumont Hospital, Dublin 9, Beaumont, Ireland.
Melotti D; Department of Haematology, Beaumont Hospital, Dublin 9, Beaumont, Ireland.
Thornton P; Department of Haematology, Beaumont Hospital, Dublin 9, Beaumont, Ireland.
Sargent J; Department of Haematology, Beaumont Hospital, Dublin 9, Beaumont, Ireland.
Conlon P; Department of Nephrology, Beaumont Hospital, Dublin 9, Beaumont, Ireland.
Murphy P; Department of Haematology, Beaumont Hospital, Dublin 9, Beaumont, Ireland.
Quinn J; Department of Haematology, Beaumont Hospital, Dublin 9, Beaumont, Ireland. johnquinn@beaumont.ie.

Ir J Med Sci ; 188(3): 1079-1080, 2019 08.

Article em En | MEDLINE | ID: mdl-30569372

Palavras-chave

Daratumumab; Dialysis independence; Dialysis-dependant renal failure; Multiple myeloma

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Ir J Med Sci Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Irlanda

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google